Results 101 to 110 of about 231,020 (192)

Evaluating methodological constraints in PET imaging of neuropeptide Y2 receptors with N-[11C]-methyl-(R)-JNJ-31020028 in brains of C57BL/6J mice

EJNMMI Radiopharmacy and Chemistry
Background The Neuropeptide Y (NPY) system regulates mood, stress, and feeding behavior and plays a central role in neuropsychiatric and metabolic disorders.
Karsten Bamminger, Eduardo Felipe Alves Fernandes, Lena Zachhuber, Ines Lopez-Martinez, Claudia Kuntner, Oliver Langer, Severin Mairinger, Berit Ø. Christoffersen, Marcus Hacker, Thomas Wanek   +9 more
doaj   +1 more source

Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer

Cancer & Metabolism
Background Malignant ascites is a common complication of advanced ovarian cancer (OC) and gastrointestinal cancer (GI), significantly impacting metastasis, quality of life, and survival.
Sisi Deng, Wooyong Kim, Kefan Cheng, Qianlu Yang, Yogesh Singh, Gyuntae Bae, Nicolas Bézière, Lukas Mager, Stefan Kommoss, Jannik Sprengel, Christoph Trautwein   +10 more
doaj   +1 more source

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients

Biomarker Research
Cell- and antibody-based CD19-directed therapies have demonstrated great potential for treating B-cell non-Hodgkin lymphoma (B-NHL). However, all these approaches suffer from limited response rates and considerable toxicity.
Dominik Sonanini, Johannes Schwenck, Simone Blaess, Julia Schmitt, Andreas Maurer, Walter Ehrlichmann, Malte Ritter, Julia Skokowa, Manfred Kneilling, Gundram Jung, Falko Fend, Simon Krost, Christian M. Seitz, Peter Lang, Gerald Reischl, Rupert Handgretinger, Christian la Fougère, Bernd J. Pichler   +17 more
doaj   +1 more source

Why the preclinical imaging field needs nuclear medicine technologists and radiographers? [PDF]

Eur J Hybrid Imaging, 2020
Dillenseger JP, Choquet P, Snay ER, Fragoso Costa P.   +3 more
europepmc   +1 more source

Protocols for Dual Tracer PET/SPECT Preclinical Imaging. [PDF]

Front Phys, 2020
Blower JE, Bordoloi JK, Rigby A, Farleigh M, Kim J, O'Brien H, Jackson J, Poyiatzis C, Bezer J, Sunassee K, Blower PJ, Livieratos L.   +11 more
europepmc   +1 more source

A Fluorescent Probe as a Lead Compound for a Selective α‑Synuclein PET Tracer: Development of a Library of 2‑Styrylbenzothiazoles and Biological Evaluation of [18F]PFSB and [18F]MFSB

ACS Omega, 2023
Adriana Di Nanni, Ran Sing Saw, Umberto M. Battisti, Gregory D. Bowden, Adam Boeckermann, Kaare Bjerregaard-Andersen, Bernd J. Pichler, Kristina Herfert, Matthias M. Herth, Andreas Maurer   +9 more
doaj   +1 more source

Tomographic Ultrasound and LED-Based Photoacoustic System for Preclinical Imaging. [PDF]

Sensors (Basel), 2020
Francis KJ, Booijink R, Bansal R, Steenbergen W.   +3 more
europepmc   +1 more source

[68Ga]Ga-DOTAGA-Glu(FAPi)2 Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging

The use of fibroblast activation protein inhibitors (FAPis) for positron emission tomography (PET) imaging in cancer has garnered significant interest in recent years, yielding promising results in preclinical and clinical settings.
Matthias Manfred Herth, Andreas Kjaer, Mortensen, Julie van Krimpen, Lund, Emilie Graae, Herth, Matthias Manfred, Simona Mattiussi, Roesch, Frank, Battisti, Umberto Maria, Umberto Maria Battisti, Mattiussi, Simona, Vladimir Shalgunov, Shalgunov, Vladimir, Hvass, Lars, Julie van Krimpen Mortensen, Frank Roesch, Kjaer, Andreas, Emilie Graae Lund, Lars Hvass   +17 more
core   +1 more source

Radiomics in preclinical imaging research: methods, challenges and opportunities. [PDF]

Npj Imaging
Riberdy V, Guida A, Rioux J, Brewer K.
europepmc   +1 more source

A Preliminary Investigation into the Use of Edge Illumination X-ray Phase Contrast Micro-CT for Preclinical Imaging. [PDF]

Mol Imaging Biol, 2020
Hagen CK, Endrizzi M, Towns R, Meganck JA, Olivo A.   +4 more
europepmc   +1 more source